Publications

Translatome profiling reveals opposing alterations in inhibitory and excitatory neurons of fragile X mice and identifies EPAC2 as a therapeutic target

 52
Translatome profiling reveals opposing alterations in inhibitory and excitatory neurons of fragile X mice and identifies EPAC2 as a therapeutic target

Tags:

Previous Article

How chemotherapy influences cancer inflammation

Next Article

New drug target identified for Fragile X syndrome

Related Posts

DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth

DNA fragmentation factor B suppresses interferon to ena...

 84

Targeting microRNA-dependent control of X chromosome inactivation improves the Rett Syndrome phenotype

Targeting microRNA-dependent control of X chromosome in...

 116

The extracellular matrix in cancer: from understanding to targeting

The extracellular matrix in cancer: from understanding ...

 198